Show
Sort by
-
- Journal Article
- A1
- open access
Contemporary management of locally advanced and recurrent rectal cancer : views from the PelvEx Collaborative
-
Is PIPAC a treatment option in upper and lower gastrointestinal cancer with peritoneal metastasis?
-
- Journal Article
- A1
- open access
Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis
-
- Journal Article
- A1
- open access
Variability drivers of treatment costs in hospitals : a systematic review
-
- Journal Article
- A1
- open access
Preclinical in vivo-models to investigate HIPEC : current methodologies and challenges
-
Incidentally found mucinous epithelial tumors of the appendix with or without pseudomyxoma peritonei : diagnostic and therapeutic algorithms based on current evidence
-
Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced‐stage ovarian cancer
-
Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) versus surgery without HIPEC for goblet-cell carcinoids and mixed adenoneuroendocrine carcinomas : propensity score-matched analysis of centers in the Netherlands and Belgium
-
Standardizing training for pressurized intraperitoneal aerosol chemotherapy
-
Intraperitoneal chemotherapy for peritoneal metastases : an expert opinion
-
The role of the peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis
-
PKPD modeling and dosing considerations in advanced ovarian cancer patients treated with cisplatin-based intraoperative intraperitoneal chemotherapy
-
- Journal Article
- A1
- open access
Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer
-
Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice.
-
Hyperthermic intraperitoneal chemotherapy in ovarian cancer
-
The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases : results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)
-
Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? : results of a multicenter international study
-
Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC)
-
The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies
-
Animal models of colorectal peritoneal metastasis
-
- Journal Article
- A1
- open access
Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model
-
- Journal Article
- A1
- open access
BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis
-
Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models
-
Clinical value of 18F-FDG- PET-CT in the preoperative staging of peritoneal carcinomatosis from colorectal origin
-
Whole abdominopelvic radiotherapy in the palliative treatment of pseudomyxoma peritonei
-
Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin
-
- Journal Article
- A1
- open access
Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent
-
Current management of peritoneal carcinomatosis from colorectal cancer
-
Use of pneumatic nebulization and laser ablation-inductively coupled plasma-mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug
-
- Journal Article
- A1
- open access
Development of a nanocrystalline Paclitaxel formulation for HIPEC treatment
-
Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model
-
Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence
-
Surgery for peritoneal carcinomatosis from colorectal origin: techniques and limitations